Ticker Attention Investors: Beware of fraudulent Calls, SMS or Emails assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Mobile Invest / TradeLite App only from Google Play Store or Apple App Store. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

J B Chemicals & Pharmaceuticals Ltd

Symbol : JBCHEPHARM | BSE Code : 506943 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

1,888.80-16.45 (-0.86%)
02-May-2024 | 02:59
Loading

Market Cap (₹ Cr.)

29,568.49
Today’s High / Low
1,911.30
1,882.00
52 Week High / Low
1,940.00
875.00
OVERVIEW
  • Open
  • 1,895.00
  • Prev. Close
  • 1,905.25
  • High
  • 1,911.30
  • Low
  • 1,882.00
  • Market Cap (₹ Cr.)
  • 29,568.49
  • 52 Week High
  • 1,940.00
  • 52 Week Low
  • 875.00
  • Traded Volume (Lacs)
  • 152,790
  • Traded Value (Cr)
  • Dividend Yield
  • 0.46
  • Face Value
  • 1.00
  • EPS
  • 32.62
  • P/E
  • 58.37
  • Beta (1 year)
  • 1.02
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY -61.68%

  • 02/05/2024 BSE
    -2.20(-0.12)
    Close Price: ₹ 1,904.10
    Volume: 2,161.00

    30-Apr-2024
  • 02/05/2024 BSE
    42.25(2.27)
    Close Price: ₹ 1,906.30
    Volume: 2,921.00

    29-Apr-2024
  • 02/05/2024 BSE
    8.85(0.48)
    Close Price: ₹ 1,864.05
    Volume: 973.00

    26-Apr-2024
  • 02/05/2024 BSE
    30.75(1.69)
    Close Price: ₹ 1,855.20
    Volume: 7,046.00

    25-Apr-2024
  • 02/05/2024 BSE
    41.05(2.30)
    Close Price: ₹ 1,824.45
    Volume: 4,047.00

    24-Apr-2024

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY -61.68%

  • Stock Absolute
  • 6.77
  • 12.85
  • 83.07
  • 172.98
  • 1,006.84
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • 1.01
  • 0.63
  • 21.40
  • 52.68
  • 90.83
NEWS

J B Chemicals & Pharmaceuticals Ltd - JB Chemicals & Pharmaceuticals Limited - Updates

29-Apr-2024

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 .

29
Apr

J B Chemicals & Pharmaceuticals Ltd - JB Chemicals & Pharmaceuticals Limited - Updates



18
Apr

J B Chemicals & Pharmaceuticals Ltd - JB Chemicals & Pharmaceuticals Limited - Disclosure under SEBI Takeover Regulations



12
Apr

J B Chemicals & Pharmaceuticals Ltd gains for third consecutive session



FINANCIAL DATA

In Cr.

Mar 2023Mar 2022Mar 2021
SOURCES OF FUNDS :   
Share Capital 15.4815.4615.46
Reserves Total 2,426.982,088.211,791.00
Equity Share Warrants0.000.000.00
Equity Application Money0.030.000.00
Read More
Mar 2023Mar 2022Mar 2021
INCOME :   
Sales Turnover 2,884.162,189.881,892.00
Excise Duty0.000.000.00
Net Sales2,884.162,189.881,892.00
Other Income 8.6538.61115.92
Read More
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales 800.10836.76852.58
Excise Duty 000
Net Sales 800.10836.76852.58
Other Operating Income 000
Other Income  6.616.845.13
Read More
Category No. Of Shares Percentage (%)
Total Foreign 18423411 11.87
Total Institutions 28528327 18.38
Total Govt Holding 8596 0.01
Total Non Promoter Corporate Holding 839753 0.54
Total Promoters 83464664 53.78
Total Public & others 23,930,049.00 15.42
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Read More
Record Date Ex-Bonus Date Ratio
30-10-1998 05-10-1998 1:1
Read More
Record Date Split Date Face Value Before Face Value After
18-09-2023 18-09-2023 2 1
12-04-2005 05-04-2005 10 2
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
06-02-2024 16-02-2024 550 Interim
24-05-2023 17-08-2023 462.5 Final
08-02-2023 17-02-2023 425 Interim
26-05-2022 12-08-2022 400 Final
14-02-2022 23-02-2022 425 Interim
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
07-04-2024 08-04-2024 Postal Ballot Notice Newspa...
07-04-2024 NA JB CHEMICALS & PHARMACEUTICALS...
31-03-2024 NA Declaration of interim dividen...
12-03-2024 NA Trading Members of the Exchang...
09-03-2024 NA Demise of Mr. Ranjit Shahani -...
COMPANY INFO

J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95. Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd.

JBC had a tie-up with Justesa Imagen, Spain, to manufacture and market radio diagnostics under the Trazograf brand name. JBC has also diversified into high-growth agro-based products by acquiring McDa Agro (MAL). The products manufactured by MAL complement fertilisers and increase crop productivity. It has entered into a MoU with GNFC to distribute these products locally. The pharmaceutical divisions of Ifiunik Pharmaceuticals and Unique Pharmaceutical Laboratories has been merged into the company with effect from April 2000.

Unique Chemicals (A Division of the company) manufacturing and marketing Bulk Drugs has been awarded Certificate of Suitability to Europeon Pharmacopoeia Monograph for Nifedipine EP from Europeon Directorate for the Quality Medicines.

In Feb. 2002 the company has achieved another break through in its major R & D Activity - Invention biologically active molecules - New Chemical Entity. In 2001-02 the company introduced 3 products Reducin XX and two in the Cholesterol reducing segment i.e., Ifistatin and Vasolip. The company has launched five new products during the year 2003-04 in the global markets to widen its product portfolio. During 2004-05, the company launched new products Cephalosporins, Moviz and its expansi

Read More